XML 24 R15.htm IDEA: XBRL DOCUMENT v3.25.2
Financial Instruments and Risk Management
9 Months Ended
Jul. 31, 2025
Financial Instruments and Risk Management [Abstract]  
Financial Instruments and Risk Management
10. Financial Instruments and Risk Management

 

  a. Assets and liabilities measured at fair value on a recurring basis were presented in the Company’s statement of financial position as of July 31, 2025, as follows:

 

   Fair Value Measurements Using     
   Quoted prices
in active
 markets
for identical
instruments
(Level 1)
   Significant
other
observable
inputs
(Level 2)
   Significant
unobservable
inputs
(Level 3)
   Balance
July 31,
2025
 
Short-term investment- common shares  $
       –
   $
      –
   $1,084   $1,084 
Derivative warrant liabilities   
–
    
–
    2,178,700    2,178,700 

 

Assets and liabilities measured at fair value on a recurring basis were presented in the Company’s statement of financial position as of October 31, 2024, as follows:

 

   Fair Value Measurements Using 
   Quoted prices
in active markets
for identical
instruments
(Level 1)
   Significant
other
observable
inputs
(Level 2)
   Significant
unobservable
inputs
(Level 3)
   Balance
October 31,
2024
 
Short-term investment- common shares  $110,400   $
     –
   $
–
   $110,400 
Short-term investment- Polyrizon Warrants   
–
    
–
    178,988    178,988 
Derivative warrant liabilities   
–
    
–
    3,519,702    3,519,702 

 

The fair value of other assets and liabilities, which include cash, amounts receivable, accounts payable and accrued liabilities, and amounts due to related parties, approximate their carrying values due to the relatively short-term maturity of these instruments.

 

  b. Credit Risk

 

Financial instruments that potentially subject the Company to a concentration of credit risk consist primarily of cash and cash equivalents. The Company limits its exposure to credit loss by placing its cash with high credit quality financial institutions. The carrying amount of financial assets represents the maximum credit exposure.

 

  c. Foreign Exchange Rate Risk

 

Foreign currency risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate due to changes in foreign exchange rates. The Company is exposed to foreign currency risk to the extent that monetary assets and liabilities are denominated in a foreign currency. The Company’s subsidiary operates in Israel and has certain monetary financial instruments denominated in New Israeli Shekel and CAD. The Company has not entered into foreign exchange rate contracts to mitigate this risk.

The following table indicates the impact of foreign currency exchange risk on net working capital as of July 31, 2025. The table below also provides a sensitivity analysis of a 10% strengthening of the foreign currency against functional currencies identified which would have increased (decreased) the Company’s net loss by the amounts shown in the table below. A 10% weakening of the foreign currency against the functional currencies would have had the equal but opposite effect as of July 31, 2025.

 

Cash and cash equivalents  $116,250 
Other receivables   28,725 
Accounts payable and accrued liabilities   (65,080)
Due to related parties   (39,820)
Total foreign currency financial assets and liabilities  $40,075 
      
Impact of a 10% strengthening or weakening of foreign exchange rate  $4,008 

 

  d. Interest Rate Risk

 

Interest rate risk is the risk that the fair value of future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The fair value of the derivative warrant liabilities can fluctuate depending on the fluctuation in the risk-free interest rate.

  

  e. Liquidity Risk

 

Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they fall due. The Company’s objective to managing liquidity risk is to ensure that it has sufficient liquidity available to meet its liabilities when due. The Company relies on raising debt or equity financing in a timely manner.

 

The following amounts are the contractual maturities of financial liabilities as of July 31, 2025 and October 31, 2024:

 

July 31, 2025  Total   Within
1 year
   Within
2-5 years
 
Accounts payable and accrued liabilities  $646,919   $646,919   $
–
 
Due to related parties   49,820    49,820    
–
 
Lease liability   28,439    28,439    
–
 
   $725,178   $725,178   $
–
 

 

October 31, 2024  Total   Within
1 year
   Within
2-5 years
 
Accounts payable and accrued liabilities  $526,056   $526,056   $
–
 
Due to related parties   48,962    48,962    
–
 
Lease liability   53,142    36,726    16,416 
   $628,160   $611,744   $16,416